Silver105QualityChecker

Utility description: Silver-105

Silver-105 Quality Checker — Silver-105 for Theranostics and PET

ℹ️  Utility checks critical parameters of Silver-105:
    • Radionuclidic purity (≥99.0%)
    • Silver-106m impurity (≤0.5%)
    • Silver-110m impurity (≤0.01%) — CRITICAL!
    • Radiochemical purity (≥95%)
    • Free silver (≤5%)
    • pH, endotoxins, sterility, heavy metals

⚠️  CRITICAL: Silver-110m (T½=250 days) creates long-term waste issues.
    Free silver is toxic and causes argyria upon accumulation.

Usage:
  Silver105QualityChecker.exe                            → demo mode (console output)
  Silver105QualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Silver106mImpurityPercent,Silver110mImpurityPercent,RadiochemicalPurityPercent,FreeSilverPercent,pH,EndotoxinsEU,SterilityTest,HeavyMetalsPPM,ProductType

Example (sterility: 0=sterile, 1=contaminated):
  AG105-PEP-2026-001,300.0,99.8,0.1,0.005,98.0,2.0,6.5,30.0,0,2,PeptideConjugate

Supported product types:
• PeptideConjugate — peptide conjugates
• Nanoparticle — silver nanoparticles
• FreeIon — research (high toxicity risk)

— WHY IS THIS NEEDED?
Silver-105 (T½=41.3 days) is a promising isotope for theranostics:
• Emits Auger electrons (for therapy) and gamma quanta (for imaging/SPECT)
• Silver chemistry is well-developed (thiols, amines, nanoparticles)
• Allows creation of long-circulating drugs
• Pair isotope: Ag-111 (T½=7.45 d) for therapy/diagnostics with different characteristics

⚠️  CRITICAL:
• Radionuclidic purity ≥99.0% — presence of other isotopes is unacceptable.
• Silver-110m (T½=249.8 days) impurity ≤0.01% — CRITICAL PARAMETER. This isotope is formed during nuclear reactions on impurities or side channels. Due to very long half-life, it makes radioactive waste hazardous for years. Even trace amounts are strictly regulated.
• Silver-106m (T½=8.28 days) impurity ≤0.5% — Creates additional radiation burden.
• Radiochemical purity ≥95% — Silver tends to form colloids and bind to blood proteins if not stabilized by a reliable chelator or nanoparticle matrix.
• Free silver ≤5% — Silver ions (Ag+) are toxic. They accumulate in liver, spleen, and skin (argyria). High levels of free silver are unacceptable.
• Heavy metals ≤5 ppm — Strict control, as other metals may displace silver from complexes.
• pH 5.0–7.5, Endotoxins ≤175 EU/vial, Sterility — standard requirements.

Key features:
• Strictest control of Ag-110m impurity
• Assessment of toxicological risk (free silver)
• Support for various forms (conjugates, nanoparticles)

Critical parameters:
• Radionuclidic purity: ≥99.0%
• Ag-110m impurity: ≤0.01% (CRITICAL!)
• Ag-106m impurity: ≤0.5%
• Radiochemical purity: ≥95.0%
• Free silver: ≤5.0%
• Heavy metals: ≤5 ppm
• pH: 5.0–7.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth

💡 Usage tips:
1. Production of Ag-105 requires highly enriched targets (Pd-105) to minimize Ag-110m formation.
2. To stabilize silver ions in vivo, macrocyclic ligands or encapsulation in nanoparticles are used.
3. Free silver control is performed by TLC or HPLC with radioactivity detection.
4. Ag-105-based drugs require long-term patient follow-up due to long half-life.

⚠️ Note: Silver-105 is interesting for its Auger electrons, which have high LET at very short distances (nanometers), effective for destroying single cancer cells. However, the problem of long-lived impurities (Ag-110m) is the main barrier to wide clinical implementation.